These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3538716)

  • 1. Molecular characterization of a protein, insoluble at low temperature, produced by Clostridium botulinum type G.
    Giménez JA; Cascone O; Biscoglio de Jimenez Bonino MJ; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):179-88. PubMed ID: 3538716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of proteins, insoluble at low temperature, produced by Clostridium botulinum type C and C. subterminale. Their antigenic relationship with a similar protein synthesized by C. botulinum type G.
    Giménez JA; Vita N; Giménez DF; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):45-56. PubMed ID: 3314259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soluble proteins of the vegetative cells and spores of Clostridium botulinum type B and their toxicity].
    Nikolaeva SA
    Prikl Biokhim Mikrobiol; 1976; 12(3):449-53. PubMed ID: 792871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amino acid composition of major components of Cl. botulinum toxin of type B].
    Kliucheva VV; Saprykina TP; Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1982; 28(5):29-33. PubMed ID: 6758340
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.
    Kalb SR; Baudys J; Barr JR
    BMC Microbiol; 2015 Oct; 15():227. PubMed ID: 26494251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid in vivo assay method for type G botulinal toxin.
    Mayorga LS; de Centorbi OP; de Milan CC; Gimenez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):78-83. PubMed ID: 3307234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical cross-linking and native gel electrophoresis.
    Ledoux DN; Be XH; Singh BR
    Toxicon; 1994 Sep; 32(9):1095-104. PubMed ID: 7801345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of an esterase-active enzyme from pronase with special reference to activation of Clostridium botulinum type E progenitor toxin.
    Miura T
    Jpn J Med Sci Biol; 1974 Dec; 27(6):285-96. PubMed ID: 4619406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinal neurotoxin C1 complex genes, clostridial neurotoxin homology and genetic transfer in Clostridium botulinum.
    Hauser D; Gibert M; Marvaud JC; Eklund MW; Popoff MR
    Toxicon; 1995 Apr; 33(4):515-26. PubMed ID: 7570637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of botulinum progenitor toxins by mass spectrometry.
    Hines HB; Lebeda F; Hale M; Brueggemann EE
    Appl Environ Microbiol; 2005 Aug; 71(8):4478-86. PubMed ID: 16085839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.